Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer

Published:2017-05-12 Issue:8 Volume:16 Page:1521-1530
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Liu Chengfei,Armstrong Cameron M.,Lou Wei,Lombard Alan P.,Cucchiara Vito,Gu Xinwei,Yang Joy C.,Nadiminty Nagalakshmi,Pan Chong-xian,Evans Christopher P.,Gao Allen C.

Funder

NIH/NCI

DOD

U.S. Department of Veterans Affairs

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Cancer Treatment: Exploring the Latest Breakthroughs in Bicalutamide Delivery and Co-Delivery Nanoformulations for Cancer Therapy;Journal of Drug Delivery Science and Technology;2024-09

2. Development of novel bisphenol derivatives with a membrane-targeting mechanism as potent gram-positive antibacterial agents;European Journal of Medicinal Chemistry;2024-08

3. High Mobility Group AT-hook 2: A Biomarker Associated with Resistance to Enzalutamide in Prostate Cancer Cells;Cancers;2024-07-24

4. Deciphering the genetic and epigenetic architecture of prostate cancer;Advances in Cancer Research;2024

5. Mechanistic Insights into Harmine-Mediated Inhibition of Human DNA Methyltransferases and Prostate Cancer Cell Growth;ACS Chemical Biology;2023-05-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP